Rhinaris® Nozoil® Nasal Spray
Natural health product licensed in Canada
Oral dose analysis does not apply without an established exclusively oral route.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source |
|---|---|
| Sesamum indicum Source : Sesamum indicum seed | 100 % |
Non-medicinal ingredients
Not provided.
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes et adolescents | minimum: 12 years | minimum: 1 Pulvérisateur ; maximum: 2 Pulvérisateur | 3 Tous les jours |
Uses authorised in Canada
Lubricating and moisturizing relief for severely dry and irritated noses to ease breathing. Rhinaris® Nozoil® Nasal Spray moisturizes and lubricates severely dry, irritated noses, helping to reduce the build-up of uncomfortable dried mucus and crusts in the nostrils for easier breathing.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
For nasal use only. Consult a health care practitioner for use beyond 3 weeks. Not recommended for use in children under 12 years of age. Keep out of reach of children. Although it is unlikely that an allergic reaction would occur, patients with allergies to nuts or seeds should consult a health care professional before using Rhinaris® Nozoil® Nasal Spray. For any unexpected effects while using Rhinaris® Nozoil®, contact your doctor or pharmacist. Consult a health care practitioner prior to use if you have a condition which reduces the clearance of mucus from the airways, such as cystic fibrosis or primary ciliary dyskinesia.
Product record
- Other names
- Rhinaris® Nozoil®
- Licence holder
- PendoPharm, Division of/de Pharmascience Inc.
- NPN or DIN-HM
- 80058002
- Status
- Active licence
- Licence date
- 6 February 2015
- Revision date
- 1 December 2020
- Form
- Vaporisateur
- Route of administration
- Nasale
- Application type
- Non traditionnelle
Source
Official Health Canada record, licence 80058002
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “Rhinaris® Nozoil® Nasal Spray (PendoPharm, Division of/de Pharmascience Inc.): composition and ingredients”, https://compoatlas.com/en/supplements/canada/80058002-rhinaris-nozoil-nasal-spray, updated 1 December 2020.